Blog - Page 3868 of 5179

MondayNov 03, 2008 4:31 am

Avanir Pharmaceuticals (NASDAQ: AVNR)

Avanir Pharmaceuticals (NASDAQ: AVNR) is dedicated to acquiring, developing, and commercializing innovative therapeutic products designed to treat chronic diseases. Zenvia™, the company’s lead product candidate, is currently being developed to treat pseudobulbar affect (PBA). GlaxoSmithKline Consumer Healthcare currently markets Avanir’s first commercialized product, Abreva®, in North America. Abreva is the leading over-the-counter product for the treatment of cold sores. For further information, visit the Company's web site at www.avanir.com.

MondayNov 03, 2008 4:31 am

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS)

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS), a biopharmaceutical company, is focused on developing, manufacturing, and marketing a broad array of products based upon the shelf-stable Microcyn® Technology platform, which has been designed to help prevent and treat infections in wounds, burns and diseases. The Microcyn platform has shown capabilities of safely treating a wide range of pathogens, including antibiotic-resistant strains of bacteria such as MRSA, viruses, fungi and spores. For further information, visit the Company's web site at www.oculusis.com.

MondayNov 03, 2008 4:30 am

NutraCea (OTC BB: NTRZ)

NutraCea (OTC BB: NTRZ) is focused on processing and distribution stabilized rice bran and other proprietary, rice bran-based ingredients and formulations. Until recently, rice bran and germ were considered as a unnecessary by-product of the commercial rice-milling industry, but NutraCea recognized its unlimited potential as food and nutraceuticals ingredient. The company believes rice bran is positioned to become one of the world’s leading food ingredients for food manufacturers, nutraceuticals, humanitarian aid, as well as petfood and feed manufacturers. For further information, visit the Company's web site at www.nutracea.com.

MondayNov 03, 2008 4:30 am

Avalon Pharmaceuticals, Inc. (NASDAQ: AVRX)

Avalon Pharmaceuticals, Inc. (NASDAQ: AVRX), a biopharmaceutical company, is committed to discovering, developing and commercializing superior cancer therapeutics. The company's proprietary platform, AvalonRx®, is designed to discover and develop therapeutics for pathways that have been characterized as "undruggable” in the past. For further information, visit the Company's web site at www.avalonrx.com.

MondayNov 03, 2008 4:30 am

Nuinsco Resources Limited (TSX: NWI CN)

Nuinsco Resources Limited (TSX: NWI CN), a growth-oriented, multi-commodity mineral exploration and development company, is focused on growing through the exploration and development of world-class mineralized belts in Canada and Turkey. The company also holds equity positions in near-production Victory Nickel Inc. (TSX:Ni), polymetallic producer Gold Hawk Resources Inc. (TSXV:CGK) and copper and gold producer Campbell Resources Inc. (TSX:CCH). For further information, visit the Company's web site at www.nuinsco.ca.

MondayNov 03, 2008 4:30 am

Ausam Energy Corporation (TSX: AZE CN)

Ausam Energy Corporation (TSX: AZE CN) is focused on oil & natural gas development and exploration in the Gulf Coast of the United States. The company currently has two producing wells in Texas and Louisiana. Ausam Energy’s 19 prospects and leads located onshore in the Gulf Coast region of the United States encompass more than 90,000 gross acres (50,000 net acres) and diversifies the company’s portfolio in areas of known commercial petroleum production with established infrastructure and gas markets. For further information, visit the Company's web site at www.ausamenergy.com.

MondayNov 03, 2008 4:29 am

NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST)

NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST) is focused on developing, manufacturing, and commercializing medical products designed to fight infection and inflammation based on the company’s patented atomically disordered nanocrystalline silver technology. NUCRYST has found success developing and manufacturing Acticoat™ dressings with SILCRYST™ nanocrystals for Smith & Nephew plc. These products are currently in use by hospitals, clinics, burn centers, doctor’s offices, home healthcare agencies and nursing homes around the globe. For further information, visit the Company's web site at www.nucryst.com.

MondayNov 03, 2008 4:29 am

ATS Medical, Inc. (NASDAQ: ATSI)

ATS Medical, Inc. (NASDAQ: ATSI) is focused on providing novel products and services designed specifically for cardiac surgery. Over 160,000 ATS Open Pivot(R) Heart Valves have been implanted in patients around the globe. ATS’ 3f(R) brand includes multiple tissue heart valve product offerings at varying steps from market introductions and clinical trials to development projects that utilize less invasive valve replacement technology. For further information, visit the Company's web site at www.atsmedical.com.

MondayNov 03, 2008 4:29 am

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP)

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is focused on the development of specialty therapeutics for gastrointestinal and endocrine disorders. Currently, the company is progressing two late-stage programs: GATTEX™ (teduglutide), which is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome; and NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection), which is in Phase 2 clinical development as a hormone therapy for hypoparathyroidism. For further information, visit the Company's web site at www.npsp.com.

MondayNov 03, 2008 4:28 am

Novelos Therapeutics, Inc. (OTC BB: NVLT)

Novelos Therapeutics, Inc. (OTC BB: NVLT), a biopharmaceutical company, has its focus on commercializing oxidized glutathione-based compounds for the treatment of Cancer and Hepatitis. The company’s lead compound in Phase 3 development for lung cancer under a Special Protocol Assessment (SPA) and Fast Track, NOV-002, acts together with chemotherapy as a chemoprotectant and chemopotentiator by regulating redox-sensitive cell signaling pathways. For further information, visit the Company's web site at www.novelos.com.

Site Search

Company Search

Avanir Pharmaceuticals (NASDAQ: AVNR)

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS)

NutraCea (OTC BB: NTRZ)

Avalon Pharmaceuticals, Inc. (NASDAQ: AVRX)

Nuinsco Resources Limited (TSX: NWI CN)

Ausam Energy Corporation (TSX: AZE CN)

NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST)

ATS Medical, Inc. (NASDAQ: ATSI)

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP)

Novelos Therapeutics, Inc. (OTC BB: NVLT)

Market Basics

Newsletter Publishers

Public Companies